Seeking Alpha

Cockrell Group's  Instablog

Cockrell Group
Send Message
The Cockrell Group, Inc. is a strategic capital markets development firm focused on small-to-midcap companies. It aligns a company's strategic goals to an institution's investment thesis and fundamentals to create a sound, long-term investment objective. The company also advises companies in... More
My company:
COCKRELL GROUP Research
  • AxoGen, Inc. Announces Release Dates For 2012 Third Quarter Results And Conference Call  0 comments
    Oct 25, 2012 1:33 PM | about stocks: AXGN, PDLI, BMTI, RTIX

    ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (NASDAQ:AXGN) a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions, today announced that it will release its financial results for the period ended September 30, 2012, on November 7, 2012 after the close of U.S. financial markets. A conference call hosted by Karen Zaderej, Chief Executive Officer, and Greg Freitag, Chief Financial Officer, will follow at 11:00 a.m. ET, on November 8, 2012.

    Conference dial-in: 877-709-8150

    International dial-in: 201-689-8354

    Webcast: www.axogeninc.com/investors.html

    A webcast replay of the conference call will be available on the Company's website, www.axogeninc.com, under "Investors."

    About AxoGen, Inc.
    AxoGen (AXGN) is a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. AxoGen's products offer a full suite of surgical nerve reconstruction solutions including Avance® Nerve Graft, the only commercially available processed nerve allograft for bridging severed nerves, AxoGuard® Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and AxoGuard® Nerve Protector, a bioscaffold used to reinforce a coaptation site, wrap a partially severed nerve or isolate and protect nerve tissue. For more information, visit our website at www.axogeninc.com.

    AxoGen is the parent of its wholly owned operating subsidiary, AxoGen Corporation. AxoGen's principal executive office and operations are located in Alachua, FL.

    To receive email alerts directly from AxoGen, please click here www.axogeninc.com/emailalerts.html.

    Contacts

    COCKRELL GROUP
    Rich Cockrell, 212-521-4138
    investorrelations@thecockrellgroup.com
    www.cockrellgroup.com
    or
    AxoGen, Inc.
    Greg Freitag, 386-462-6856
    Chief Financial Officer
    InvestorRelations@axogeninc.com

    www.axogeninc.com

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Back To Cockrell Group's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

  • AxoGen, Inc. $AXGN CEO Karen Zaderej, expected to appear on FOX Business' "After the Bell" with Liz Claman today at 4PM ET
    May 4, 2015
  • Bacterin $BONE CEO on "After the Bell" with Liz Claman at 4:20PM ET
    Nov 11, 2014
  • SUPN: 2013 Revenues Exceed Analyst Company's Expectations; Maintaining Positive Outlook $SUPN http://seekingalpha.com/a/18t9v
    Mar 16, 2014
More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.